Dexilant® 特胃能® Takeda
參考資料
  1. Metz DC, et al., Aliment Pharmacol Ther 2009;29:742-54
  2. Kukulka M, et al., Clin Exp Gastroenterol 2011:4 213–220
  3. Dexilant package insert USPI-JUN2018-HK-SEP2018
  4. U.S. Food and Drug Administration (FDA). Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022287s019lbl.pdf (Last accessed: Oct 2019).
  5. Fock KM, et al., J  Gastroenterol Hepatol 2008;23(1):8-22
  6. Katz PO, et al., Aliment Pharmacol Ther 2006;23 (Suppl.2): 9-22
  7. Goh KL, et al., J Gastroenterol Hepatol 2014;29:1969-75
  8. Fass R ,et al., Am J Gastroenterol 2011; 106:421–431
  9. Lee RD, et al., Aliment Pharmacol Ther 2009 ;29(8) :824-33
  10. Tan V, et al., J Clin Gastroenterol 2016;50:e1-e7
  11. Menezes MA & Hebella FAM. World J Surg. 2017; 41(7): 1666-71.
  12. Vakily M et al., Current Medical Research and Opinion. 2009; 25:3, 627-638
  13. Wong CY. Gastro-esophageal reflux disease: Optimizing proton pump inhibitor therapy to improve symptom control. JSPHK 2014;6:1-2.